The burdens of incontinence: Quantifying incontinence product usage and costs in women.
The burdens of incontinence: Quantifying incontinence product usage and costs in women.
复制标题
DOI：
10.1002/nau.25007
复制
发表时间：
2022-09
影响因子：
2
通讯作者：
中科院分区：
文献类型：
--
作者：
尿失禁是女性的常见疾病，她们经常使用失禁控制产品来自我管理。很少有研究试图量化与失禁亚型和严重程度相关的失禁产品的使用和成本，因此本研究旨在量化失禁产品的使用和女性的个人成本。这是一个次要的分析，从一个样本的成年妇女招募电子通过ResearchMatch的泌尿系统症状和健康的社会决定因素的研究。参与者完成了关于泌尿系统症状的有效问卷，并被问及每日使用失禁产品的数量和类型以及每周的费用，沿着人口统计学和基线临床信息，以及未满足的社会需求信息。除了Wilcoxon秩和Kruskal-Wallis检验外，还进行了描述性统计，以比较基于失禁类型、症状严重程度和其他人口统计学的失禁产品使用和成本，以及多变量线性回归。702名报告每周使用失禁产品的妇女被纳入最终分析样本。总体而言，女性报告在24小时内平均使用1.8 ± 2.1件失禁产品（中位数1，四分位数间距[IQR] 1），最多32件。平均每周成本为5.42 ± 8.59美元（中位数3美元，IQR 4美元），成本高达100美元。非白人妇女倾向于使用更高的产品和成本，非西班牙裔黑人妇女和西班牙裔妇女的成本显着增加。在受教育程度较低、家庭收入低于贫困线、残疾、正在使用医疗补助或没有保险、有更多未满足的社会需求以及混合性尿失禁的妇女中，使用率和成本较高。此外，每日产品使用和每周费用随着失禁症状严重程度的增加而增加，其中症状严重和非常严重的患者之间的增幅最大。在这项研究中，我们能够量化失禁妇女每天使用的失禁产品数量和每周的费用，包括失禁的类型和严重程度。在社会需求未得到满足、医疗补助或没有保险、受教育程度低于大学、收入较低或残疾的妇女中，费用甚至更高，可能令人望而却步。
Urinary incontinence is a common condition in women, who often use incontinence containment products to self-manage. Few studies have sought to quantify use and costs of incontinence products associated with subtypes of incontinence and severity, therefore this study aimed to quantify incontinence product use and personal costs to women. This is a secondary analysis from a sample of adult women recruited electronically via ResearchMatch for a study on urinary symptoms and social determinants of health. Participants completed validated questionnaires on urinary symptoms, and were asked about daily numbers and types of incontinence products used and weekly costs, along with demographic and baseline clinical information, and information about unmet social needs. Descriptive statistics were performed, in addition to Wilcoxon rank sum and Kruskal-Wallis tests to compare incontinence product usage and cost based on type of incontinence, symptom severity, and other demographics, in addition to multivariable linear regression. 702 women who reported using weekly incontinence products were included in the final analytic sample. Overall, women reported using a mean of 1.8 ± 2.1 incontinence products in 24 hours (median 1, interquartile range [IQR] 1), with a maximum of 32. Mean weekly cost of was $5.42 ± $8.59 (median $3, IQR $4), with cost up to $100. Non-white women trended towards having higher product usage and cost, with significant cost increase seen among non-Hispanic Black women and Hispanic women. Usage and cost were higher in women who had less education, had household income below the poverty line, were on disability, were using Medicaid or were uninsured, had more unmet social needs, and in those with mixed incontinence. Additionally, daily product use and weekly costs increased with incontinence symptom severity, with the biggest increase between those with severe and very severe symptoms. In this study we were able to quantify the number of incontinence products used daily and the weekly costs in incontinent women across type and severity of incontinence. Costs were even greater, and may be prohibitive, in women with more unmet social needs, Medicaid or no insurance, less than college education, lower income, or on disability.